Last reviewed · How we verify

NCT05583643

Clinical & Biochemical Effect of Atorvastatin in Nano Particles Gel in Periodontitis Treatment

Completed Phase 1 Last updated 19 October 2022
What this trial tests

Phase 1 trial testing Atorvastatin Calcium in Periodontitis in 24 participants. Completed in 30 June 2022.

Timeline
7 December 2021
Primary endpoint
15 April 2022
30 June 2022

Quick facts

Lead sponsorMisr University for Science and Technology
PhasePhase 1
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment24
Start date7 December 2021
Primary completion15 April 2022
Estimated completion30 June 2022
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Misr University for Science and Technology

Who can join

Adults 25 to 45, any sex, with Periodontitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Periodontitis is a destructive chronic inflammatory disease characterized by periodontium damage and pocket formation between the tooth and the gingival margin resulting in ultimate tooth loss. Various topical anti-inflammatory drugs were used to treat inflammation in periodontitis. Introducing atorvastatin as a novel remedy for periodontitis treatment necessitates developing a syringeable modified delivery system capable of targeting inflammation within the periodontal pockets.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Bioresponsive engineered nanoparticles for immunomodulation.
    Hegde M, Mishra A, Banerjee R, Bintee B, et al · · 2025 · cited 4× · PMID 41162977 · DOI 10.1186/s12916-025-04305-6

Verify or expand the search:

Other trials of Atorvastatin Calcium

Trials testing the same drug.

Other recruiting trials for Periodontitis

Currently open trials in the same condition.

Other Misr University for Science and Technology trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05583643.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing